Neural Pathways builds GPU-accelerated simulation engines that model neural circuits and their interaction with candidate therapeutics. The platform is used by biotech firms and university labs to predict compound efficacy before animal studies. Partnerships with CSIRO and Florey Institute drive validation; the remote-first team collaborates with teams across Melbourne and Stockholm.